相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Validation of Plasma Amyloid-β 42/40 for Detecting Alzheimer Disease Amyloid Plaques
Yan Li et al.
NEUROLOGY (2022)
Multi-platform proteomic analysis of Alzheimer's disease cerebrospinal fluid and plasma reveals network biomarkers associated with proteostasis and the matrisome
Eric B. Dammer et al.
ALZHEIMERS RESEARCH & THERAPY (2022)
Predicting AT(N) pathologies in Alzheimer's disease from blood-based proteomic data using neural networks
Yuting Zhang et al.
FRONTIERS IN AGING NEUROSCIENCE (2022)
Comparative Analysis of Alzheimer's Disease Cerebrospinal Fluid Biomarkers Measurement by Multiplex SOMAscan Platform and Immunoassay-Based Approach
Jigyasha Timsina et al.
JOURNAL OF ALZHEIMERS DISEASE (2022)
Omics-based biomarkers discovery for Alzheimer's disease
Qiaolifan Aerqin et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2022)
Alzheimer's disease
Philip Scheltens et al.
LANCET (2021)
Meningeal lymphatics affect microglia responses and anti-Aβ immunotherapy
Sandro Da Mesquita et al.
NATURE (2021)
Prediction of future Alzheimer's disease dementia using plasma phospho-tau combined with other accessible measures
Sebastian Palmqvist et al.
NATURE MEDICINE (2021)
Genomic atlas of the proteome from brain, CSF and plasma prioritizes proteins implicated in neurological disorders
Chengran Yang et al.
NATURE NEUROSCIENCE (2021)
LRRK2 in Parkinson disease: challenges of clinical trials
Eduardo Tolosa et al.
NATURE REVIEWS NEUROLOGY (2020)
Large-scale proteomic analysis of Alzheimer's disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation
Erik C. B. Johnson et al.
NATURE MEDICINE (2020)
Shared proteomic effects of cerebral atherosclerosis and Alzheimer's disease on the human brain
Aliza P. Wingo et al.
NATURE NEUROSCIENCE (2020)
Association of CSF Aβ, amyloid PET, and cognition in cognitively unimpaired elderly adults
Tengfei Guo et al.
NEUROLOGY (2020)
Microglia Do Not Take Up Soluble Amyloid-beta Peptides, But Partially Degrade Them by Secreting Insulin-degrading Enzyme
Hongjun Fu et al.
NEUROSCIENCE (2020)
Single-Nucleus RNA-Seq Is Not Suitable for Detection of Microglial Activation Genes in Humans
Nicola Thrupp et al.
CELL REPORTS (2020)
Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer's disease
Lenora Higginbotham et al.
SCIENCE ADVANCES (2020)
2020 Alzheimer's disease facts and figures
[Anonymous]
ALZHEIMERS & DEMENTIA (2020)
Differential Expression of mRNAs in the Brain Tissues of Patients with Alzheimer's Disease Based on GEO Expression Profile and Its Clinical Significance
Guowei Ma et al.
BIOMED RESEARCH INTERNATIONAL (2019)
High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis
Suzanne E. Schindler et al.
NEUROLOGY (2019)
Multiplex proteomics identifies novel CSF and plasma biomarkers of early Alzheimer's disease
Christopher D. Whelan et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)
Cholecystokinin and Alzheimer's disease: a biomarker of metabolic function, neural integrity, and cognitive performance
Alexandra Plagman et al.
NEUROBIOLOGY OF AGING (2019)
High performance plasma amyloid-β biomarkers for Alzheimer's disease
Akinori Nakamura et al.
NATURE (2018)
Integrative computational evaluation of genetic markers for Alzheimer's disease
Zhe Li et al.
SAUDI JOURNAL OF BIOLOGICAL SCIENCES (2018)
TREM2 Function in Alzheimer's Disease and Neurodegeneration
Jason D. Ulrich et al.
ACS CHEMICAL NEUROSCIENCE (2016)
Imaging and cerebrospinal fluid biomarkers in early preclinical alzheimer disease
Andrei G. Vlassenko et al.
ANNALS OF NEUROLOGY (2016)
Neuropathology of Autosomal Dominant Alzheimer Disease in the National Alzheimer Coordinating Center Database
John M. Ringman et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2016)
CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
Bob Olsson et al.
LANCET NEUROLOGY (2016)
A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers
Clifford R. Jack et al.
NEUROLOGY (2016)
Epidermal growth factor prevents APOE4 and amyloid-beta-induced cognitive and cerebrovascular deficits in female mice
Riya Thomas et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2016)
Alzheimer's disease biomarker discovery using SOMAscan multiplexed protein technology
Martina Sattlecker et al.
ALZHEIMERS & DEMENTIA (2014)
Intranasal epidermal growth factor treatment rescues neonatal brain injury
Joseph Scafidi et al.
NATURE (2014)
Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool
Edward Y. Chen et al.
BMC BIOINFORMATICS (2013)
TREM2 is associated with the risk of Alzheimer's disease in Spanish population
Bruno A. Benitez et al.
NEUROBIOLOGY OF AGING (2013)
TREM2 Variants in Alzheimer's Disease
Rita Guerreiro et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
The sva package for removing batch effects and other unwanted variation in high-throughput experiments
Jeffrey T. Leek et al.
BIOINFORMATICS (2012)
Cerebrospinal fluid APOE levels: an endophenotype for genetic studies for Alzheimers disease
Carlos Cruchaga et al.
HUMAN MOLECULAR GENETICS (2012)
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
Randall J. Bateman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Epidermal growth factor receptor is a preferred target for treating Amyloid-β-induced memory loss
Lei Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Microglial phagocytosis induced by fibrillar β-amyloid is attenuated by oligomeric β-amyloid: implications for Alzheimer's disease
Xiao-dong Pan et al.
MOLECULAR NEURODEGENERATION (2011)
Human apoE Isoforms Differentially Regulate Brain Amyloid-β Peptide Clearance
Joseph M. Castellano et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Aptamer-Based Multiplexed Proteomic Technology for Biomarker Discovery
Larry Gold et al.
PLOS ONE (2010)
SNPs Associated with Cerebrospinal Fluid Phospho-Tau Levels Influence Rate of Decline in Alzheimer's Disease
Carlos Cruchaga et al.
PLOS GENETICS (2010)
Cerebrospinal fluid tau/β-amyloid42 ratio as a prediction of cognitive decline in nondemented older adults
Anne M. Fagan et al.
ARCHIVES OF NEUROLOGY (2007)
Mutations in LRRK2 cause autosomal-dominant Parkinsonism with pleomorphic pathology
A Zimprich et al.
NEURON (2004)
MAP kinase signaling cascade dysfunction specific to Alzheimer's disease in fibroblasts
WQ Zhao et al.
NEUROBIOLOGY OF DISEASE (2002)
分享论文
